Loading...
Lung cancer screening: who pays? who receives?—the Chinese perspective
The National Lung Screening Trial (NLST) revealed that low-dose computed tomography (LDCT) screening reduced lung cancer mortality by 20.0%. In China, LDCT is very cheap and easy to access. As a result, LDCT screening is not limited to “high-risk” population defined by the NLST trial. The results of...
Na minha lista:
| Udgivet i: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AME Publishing Company
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8182701/ https://ncbi.nlm.nih.gov/pubmed/34164286 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2020.03.16 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|